Tongli Pharmaceuticals (USA), Inc. — key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2012)

$11.1M

Total Assets (FY2012)

$8.8M

Cash Flows from Operating Activities (FY2012)

$6.0M

Source: Tongli Pharmaceuticals (USA), Inc. 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.